Codes / ICD10CM / E88.39

E88.39 Other mitochondrial metabolism disorders

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other mitochondrial metabolism disorders

Summary

Other mitochondrial metabolism disorders represent a group of conditions involving abnormalities in mitochondrial function, which disrupts cellular energy production and metabolic processes. These disorders can affect multiple organ systems, with symptoms ranging from mild to severe, depending on the specific mitochondrial pathway involved. The presentation is often heterogeneous, and diagnosis typically requires specialized testing to identify the underlying metabolic defect.

Causes

The causes of other mitochondrial metabolism disorders are diverse and may include genetic mutations affecting mitochondrial DNA or nuclear genes, enzyme deficiencies, or disruptions in mitochondrial biogenesis. Some cases result from inherited genetic defects, while others may arise from acquired factors such as toxins, medications, or metabolic stressors. The exact etiology often depends on the specific mitochondrial pathway impaired.

Risk Factors

  • Genetic predisposition or family history of mitochondrial disorders
  • Exposure to mitochondrial toxins (e.g., certain antibiotics, chemicals)
  • Underlying metabolic or systemic diseases
  • Age-related mitochondrial dysfunction
  • Nutritional deficiencies affecting mitochondrial function

Symptoms

  • Fatigue, weakness, or exercise intolerance
  • Neurological symptoms (e.g., seizures, developmental delays)
  • Muscle pain or myopathy
  • Gastrointestinal disturbances (e.g., nausea, vomiting)
  • Metabolic imbalances (e.g., lactic acidosis)
  • Organ-specific dysfunction (e.g., cardiac, hepatic)

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory testing, and specialized assessments. Blood tests may reveal metabolic abnormalities such as elevated lactate or abnormal organic acids. Imaging or tissue biopsies (e.g., muscle) can assess mitochondrial function. Genetic testing may identify specific mutations, while functional assays (e.g., respiratory chain analysis) confirm mitochondrial defects. A multidisciplinary approach is often required for accurate diagnosis.

Treatment Options

Treatment is tailored to the underlying cause and symptoms. Supportive care includes managing metabolic imbalances, providing nutritional support, and addressing organ-specific complications. Specific therapies may involve cofactor supplementation, avoiding mitochondrial toxins, or targeted medications. In some cases, gene therapy or experimental treatments may be considered, though options are limited and depend on the disorder.

Prognosis and Follow-Up

Prognosis varies widely based on the specific disorder, severity, and organ involvement. Some individuals experience mild symptoms with stable management, while others may have progressive decline. Regular follow-up with specialists (e.g., metabolic, neurology) is essential to monitor organ function, adjust treatments, and address complications. Early intervention can improve outcomes, but long-term prognosis remains uncertain for many mitochondrial disorders.

Complications

  • Progressive organ dysfunction (e.g., cardiac, neurological)
  • Metabolic crises (e.g., lactic acidosis)
  • Developmental delays or intellectual disability
  • Muscle weakness or atrophy
  • Gastrointestinal or hepatic complications
  • Increased susceptibility to infections

Lifestyle & Prevention

Lifestyle modifications focus on avoiding triggers and supporting mitochondrial health. This may include a balanced diet, regular exercise (as tolerated), and avoiding known mitochondrial toxins (e.g., certain medications). Preventive measures involve genetic counseling for families with a history of mitochondrial disorders and monitoring for early symptoms. Stress management and adequate rest are also important for symptom control.

When to Seek Professional Help

Seek medical attention if experiencing unexplained fatigue, neurological symptoms (e.g., seizures, confusion), or metabolic imbalances (e.g., nausea, vomiting). Prompt evaluation is critical for diagnosing mitochondrial disorders, as early intervention can mitigate complications. Consult a specialist if symptoms worsen or new organ-specific issues arise (e.g., cardiac palpitations, muscle pain).

Tips for Medical Coders

Document the specific mitochondrial pathway or clinical features to support coding for E88.39. Include details on diagnostic findings (e.g., genetic testing, metabolic abnormalities) and organ involvement to clarify the condition. Ensure documentation aligns with clinical criteria for mitochondrial metabolism disorders, as this code is used for conditions not classified elsewhere. Avoid using this code for unspecified or unrelated metabolic issues.

Book a walkthrough

E88.39 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.